Fused Pyrimidine-Based Drug Discovery - Heterocyclic Drug Discovery - Raj Kumar - Books - Elsevier - Health Sciences Division - 9780443186165 - October 11, 2022
In case cover and title do not match, the title is correct

Fused Pyrimidine-Based Drug Discovery - Heterocyclic Drug Discovery

Raj Kumar

Price
$ 267.49

Ordered from remote warehouse

Expected delivery Oct 11 - 25
Add to your iMusic wish list

Fused Pyrimidine-Based Drug Discovery - Heterocyclic Drug Discovery

Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural chemistry, and chemical and physical properties along with various approaches for their synthesis. This book is ideal for researchers in organic chemistry both in academic and industrial settings, postgraduates in chemistry and medicinal chemistry.


320 pages

Media Books     Paperback Book   (Book with soft cover and glued back)
Released October 11, 2022
ISBN13 9780443186165
Publishers Elsevier - Health Sciences Division
Pages 378
Dimensions 1 kg
Editor Kumar, Raj (Professor of Organic Medicinal Chemistry, Central University of Punjab, Bathinda, India)

Show all

More by Raj Kumar